Literature DB >> 6795702

Efficacy of dacarbazine imidazole carboxamide and mitomycin C combination therapy in patients with adenocarcinoma of the colon refractory to 5-fluorouracil therapy.

J F Conroy, P I Roda, I Brodsky, S B Kahn, S I Bulova, E Pequignot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6795702     DOI： 10.1007/978-3-642-81681-9_10

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN： 0080-0015


× No keyword cloud information.
  4 in total

1.  Palliative and adjunctive measures in rectal cancer.

Authors:  A Fritsch; W Seidl; C Walzel; K Moser; R Schiessel
Journal:  World J Surg       Date:  1982-09       Impact factor: 3.352

2.  Combination of dacarbazine and mitomycin in advanced colorectal cancer.

Authors:  H Bleiberg; M Clavel; C Nicaise; J Devriendt; J Michel; B Vanderlinden; M Rozencweig
Journal:  Cancer Chemother Pharmacol       Date:  1982-12       Impact factor: 3.333

3.  Combination of dacarbazine, mitomycin C, 5-fluorouracil and vincristine in advanced colorectal cancer.

Authors:  G Falkson; H L Pretorius; H C Falkson; H S Schoeman
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

4.  In vitro antineoplastic activity of C7-substituted mitomycin C analogues MC-77 and MC-62 against human breast-cancer cell lines.

Authors:  A Ghiorghis; A Talebian; R Clarke
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.